nach oben

Inflammopharmacology

Erschienen in:

01.12.2013 | Review

The multiple faces of CCL13 in immunity and inflammation

verfasst von: E. Mendez-Enriquez, E. A. García-Zepeda

Erschienen in: Inflammopharmacology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

CCL13/MCP-4, is a CC family chemokine that is chemoattractant for eosinophils, basophils, monocytes, macrophages, immature dendritic cells, and T cells, and its capable of inducing crucial immuno-modulatory responses through its effects on epithelial, muscular and endothelial cells. Similar to other CC chemokines, CCL13 binds to several chemokine receptors (CCR1, CCR2 and CCR3), allowing it to elicit different effects on its target cells. A number of studies have shown that CCL13 is involved in many chronic inflammatory diseases, in which it functions as a pivotal molecule involved in the selective recruitment of cell lineages to the inflamed tissues and their subsequent activation. Based on these studies, we suggest that blocking the actions of CCL13 can serve as a novel strategy for the generation of agents with anti-inflammatory activity. The main goal of this review is to present the current information about CCL13, its gene and protein structure and the roles of this chemokine during innate/adaptive immune responses in inflammatory diseases.

Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787–820. doi:10.1146/annurev.immunol.24.021605.090529 PubMedCrossRef

Barinka C, Prahl A, Lubkowski J (2008) Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13). Acta Crystallogr D Biol Crystallogr 64(Pt 3):273–278PubMedCrossRef

Benítez-Hernández I (2010) Proteolytic cleavage of chemokines by Trypanosoma cruzi’s cruzipain inhibits chemokine functions by promoting the generation of antagonists. Immunobiology 215(5):413–426. doi:10.1016/j.imbio.2009.06.001 PubMedCrossRef

Blease K, Mehrad B, Standiford TJ, Lukacs NW, Kunkel SL, Chensue SW, Lu B et al (2000) Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunology (Baltimore, Md.: 1950) 165(3):1564–1572

Carpenter KJ, Ewing JL, Schuh JM, Ness TL, Kunkel SL, Aparici M, Miralpeix M et al (2005) Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice. Br J Pharmacol 145(8):1160–1172. doi:10.1038/sj.bjp.0706243 PubMedCrossRef

Carroll K. N, Hartert T. V (2008) The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy clini of North Am 28(3):539–61, viii. doi:10.1016/j.iac.2008.03.001

Caux C, Ait-Yahia S, Chemin K, De Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C et al (2000) Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22(4):345–369PubMedCrossRef

Chiu B-C, Freeman CM, Stolberg VR, Hu JS, Zeibecoglou K, Lu B, Gerard C et al (2004) Impaired lung dendritic cell activation in CCR2 knockout mice. Am J Pathol 165(4):1199–1209PubMedCrossRef

Christodoulopoulos P, Wright E, Frenkiel S, Luster A, Hamid Q (1999) Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol 103(6):1036–1044

Cohn L, Elias JA, Chupp GL (2004) Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22:789–815. doi:10.1146/annurev.immunol.22.012703.104716 PubMedCrossRef

Dean RA, Cox JH, Bellac CL, Doucet A, Starr AE, Overall CM (2008) Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR + CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112(8):3455–3464PubMedCrossRef

Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H et al (2000) Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 106(3):507–513. doi:10.1067/mai.2000.108311 PubMedCrossRef

Garcia-Zepeda EA, Combadiere C, Rothenberg ME, Sarafi MN, Lavigne F, Hamid Q, Murphy PM et al (1996) Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J Immunol 157(12):5613–5626PubMed

Godiska R, Chantry D, Raport CJ, Schweickart VL, Trong HL, Gray PW (1997) Monocyte chemotactic protein-4: tissue-specific expression and signaling through CC chemokine receptor-2. J Leukoc Biol 61(3):353–360PubMed

Hashimoto I, Wada J, Hida A, Baba M, Miyatake N, Eguchi J, Shikata K et al (2006) Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects. Obesity (Silver Spring, Md.) 14(5):799–811. doi:10.1038/oby.2006.93 CrossRef

Hein H, Schlüter C, Kulke R, Christophers E, Schröder JM, Bartels J, Schluter C et al (1999) Genomic organization, sequence analysis and transcriptional regulation of the human MCP-4 chemokine gene (SCYA13) in dermal fibroblasts: a comparison to other eosinophilic beta-chemokines. Biochem Biophys Res Commun 255(2):470–476. doi:10.1006/bbrc.1999.0216 PubMedCrossRef

Hintzen C, Quaiser S, Pap T, Heinrich PC, Hermanns HM (2009) Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis. Arthritis Rheum. doi:10.1002/art.24602 PubMed

Iwamoto T, Okamoto H, Iikuni N, Takeuchi M, Toyama Y, Tomatsu T, Kamatani N et al (2006) Monocyte chemoattractant protein-4 (MCP-4)/CCL13 is highly expressed in cartilage from patients with rheumatoid arthritis. Rheumatology (Oxford) 45(4):421–424. doi:10.1093/rheumatology/kei209 CrossRef

Iwamoto T, Okamoto H, Kobayashi S, Ikari K, Toyama Y, Tomatsu T, Kamatani N et al (2007) A role of monocyte chemoattractant protein-4 (MCP-4)/CCL13 from chondrocytes in rheumatoid arthritis. FEBS J 274(18):4904–4912PubMedCrossRef

Iwamoto Takuji, Okamoto H, Toyama Y, Momohara S (2008) Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 275(18):4448–4455. doi:10.1111/j.1742-4658.2008.06580.x PubMedCrossRef

Joubert P, Lajoie-Kadoch S, Labonté I, Gounni AS, Maghni K, Wellemans V, Chakir J et al (2005) CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol (Baltimore, Md.: 1950) 175(4):2702–2708

Joubert P, Lajoie-Kadoch S, Welman M, Dragon S, Létuvée S, Tolloczko B, Halayko AJ et al (2008) Expression and regulation of CCR1 by airway smooth muscle cells in asthma. J Immunol (Baltimore, Md.: 1950) 180(2):1268–1275

Kalayci O, Birben E, Wu L, Oguma T, Storm Van’s Gravesande K, Subramaniam V, Sheldon HK et al (2003) Monocyte chemoattractant protein-4 core promoter genetic variants: influence on YY-1 affinity and plasma levels. Am J Respir Cell Mole Biol 29(6):750–756. doi:10.1165/rcmb.2003-0024OC CrossRef

Kalayci O, Sonna LA, Woodruff PG, Camargo CA Jr, Luster AD, Lilly CM, Camargo CA (2004) Monocyte chemotactic protein-4 (MCP-4; CCL-13): a biomarker of asthma. J Asthma 41(1):27–33PubMedCrossRef

Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA, Skov PS et al (2000) Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 95(6):1911–1917PubMed

Koenen RR, Weber C (2010) Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov 9(2):141–153. doi:10.1038/nrd3048 PubMedCrossRef

Kohan M, Puxeddu I, Reich R, Levi-Schaffer F, Berkman N (2010) Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Annals Allergy Asthma Immunol 104(1):66–72CrossRef

Lagu B, Gerchak C, Pan M, Hou C, Singer M, Malaviya R, Matheis M et al (2007) Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma. Bioorg Med Chem Lett 17(15):4382–4386. doi:10.1016/j.bmcl.2007.01.115 PubMedCrossRef

Lambrecht BN, Hammad H (2012) The airway epithelium in asthma. Nat Med 18(5):684–692. doi:10.1038/nm.2737 PubMedCrossRef

Lamkhioued B, Garcia-Zepeda EA, Abi-Younes S, Nakamura H, Jedrzkiewicz S, Wagner L, Renzi PM et al (2000) Monocyte chemoattractant protein (MCP)-4 expression in the airways of patients with asthma. Induction in epithelial cells and mononuclear cells by proinflammatory cytokines. Am J Respir Crit Care Med 162(2 Pt 1):723–732PubMedCrossRef

Luster AD (1998) Chemokines–chemotactic cytokines that mediate inflammation. New Engl J Med 338(7):436–445PubMedCrossRef

Luster AD, Rothenberg ME (1997) Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 62(5):620–633PubMed

Maho A, Carter A, Bensimon A, Vassart G, Parmentier M (1999) Physical mapping of the CC-chemokine gene cluster on the human 17q11. 2 region. Genomics 59(2):213–223. doi:10.1006/geno.1999.5850 PubMedCrossRef

Martinez-Becerra F, Silva DA, Dominguez-Ramirez L, Mendoza-Hernandez G, Lopez-Vidal Y, Soldevila G, Garcia-Zepeda EA (2007) Analysis of the antimicrobial activities of a chemokine-derived peptide (CDAP-4) on Pseudomonas aeruginosa. Biochem Biophys Res Commun 355(2):352–358PubMedCrossRef

McQuibban GA, Gong J-H, Wong JP, Wallace JL, Clark-Lewis I, Overall CM (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100(4):1160–1167PubMed

Mendez-Enriquez E, Melendez Y, Martinez F, Baay G, Huerta-Yepez S, Gonzalez-Bonilla C, Fortoul TI et al (2008) CDIP-2, a synthetic peptide derived from chemokine (C–C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation. Clin Exp Immunol 152(2):354–363PubMedCrossRef

Nakajima H, Iwamoto I (2005) Pathogenesis of asthma. Nippon Rinsho 63 Suppl 5(6):53–57PubMed

Nakamura H, Luster AD, Tateno H, Jedrzkiewicz S, Tamura G, Haley KJ, Garcia-Zepeda EA et al (2001) IL-4 differentially regulates eotaxin and MCP-4 in lung epithelium and circulating mononuclear cells. Am J Physiol Lung Cell Mol Physiol 281(5):L1288–L1302PubMed

Nonaka M, Fukumoto A, Ogihara N, Pawankar R, Sakanushi A, Yagi T (2007) Expression of MCP-4 by TLR ligand-stimulated nasal polyp fibroblasts. Acta Otolaryngol 127(12):1304–1309. doi:10.1080/00016480701242444

Ockinger J, Stridh P, Beyeen AD, Lundmark F, Seddighzadeh M, Oturai A, Sorensen PS et al (2009) Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun 11(2):142–154PubMedCrossRef

Osterholzer JJ, Ames T, Polak T, Sonstein J, Moore BB, Chensue SW, Toews GB et al (2005) CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J Immunol (Baltimore, MD.: 1950) 175(2):874–883

Pease JE (2011) Targeting chemokine receptors in allergic disease. Biochem J 434(1):11–24. doi:10.1042/BJ20101132 PubMedCrossRef

Pease JE, Horuk R (2010) Small molecule antagonists of chemokine receptors–is promiscuity a virtue? Curr Top Med Chem 10(13):1351–1358PubMedCrossRef

Pertuz Belloso S, Ostoa Saloma P, Benitez I, Soldevila G, Olivos A, Garcia-Zepeda E (2004) Entamoeba histolytica cysteine protease 2 (EhCP2) modulates leucocyte migration by proteolytic cleavage of chemokines. Parasite Immunol 26(5):237–241PubMedCrossRef

Pigard N, Elovaara I, Kuusisto H, Paalavuo R, Dastidar P, Zimmermann K, Schwarz H-P et al (2009) Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression. J Neuroimmunol 209(1–2):114–120. doi:10.1016/j.jneuroim.2009.01.014 PubMedCrossRef

Pype JL, Dupont LJ, Menten P, Van Coillie E, Opdenakker G, Van Damme J, Chung KF et al (1999) Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 21(4):528–536PubMedCrossRef

Rossi L, Moharram R, Martin BM, White RL, Panelli MC (2006) Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture. J Transl Med 4:5PubMedCrossRef

Santiago J, Hernández-Cruz JL, Manjarrez-Zavala ME, Montes-Vizuet R, Rosete-Olvera DP, Tapia-Díaz AM, Zepeda-Peney H et al (2008) Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 32(5):1243–1249. doi:10.1183/09031936.00085107 CrossRef

Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100(12):7265–7270. doi:10.1073/pnas.1133870100 PubMedCrossRef

Sato W, Aranami T, Yamamura T (2007) Cutting edge: Human Th17 cells are identified as bearing CCR2 + CCR5- phenotype. J Immunol (Baltimore, MD.: 1950) 178(12):7525–7529

Schober A, Zernecke A, Liehn EA, Von Hundelshausen P, Knarren S, Kuziel WA, Weber C (2004) Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res 95(11):1125–1133. doi:10.1161/01.RES.0000149518.86865.3e PubMedCrossRef

Sheikine Y, Hansson GK (2004) Chemokines and atherosclerosis. Ann Med 36(2):98–118PubMedCrossRef

Stellato C, Collins P, Ponath PD, Soler D, Newman W, La Rosa G, Li H et al (1997) Production of the novel C–C chemokine MCP-4 by airway cells and comparison of its biological activity to other C–C chemokines. J Clin Invest 99(5):926–936. doi:10.1172/JCI119257 PubMedCrossRef

Tenscher K, Metzner B, Hofmann C, Schopf E, Norgauer J, Schöpf E (1997) The monocyte chemotactic protein-4 induces oxygen radical production, actin reorganization, and CD11b up-regulation via a pertussis toxin-sensitive G-protein in human eosinophils. Biochem Biophys Res Commun 240(1):32–35. doi:10.1006/bbrc.1997.7601 PubMedCrossRef

Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li H, Lima SH, Li Y et al (1996) Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 183(5):2379–2384PubMedCrossRef

Vaidehi N, Schlyer S, Trabanino RJ, Floriano WB, Abrol R, Sharma S, Kochanny M et al (2006) Predictions of CCR1 chemokine receptor structure and BX 471 antagonist binding followed by experimental validation. J Biol Chem 281(37):27613–27620. doi:10.1074/jbc.M601389200 PubMedCrossRef

Van Coillie E, Van Damme J, Opdenakker G (1999) The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 10(1):61–86PubMedCrossRef

Vanbervliet B, Homey B, Durand I, Massacrier C, Aït-Yahia S, De Bouteiller O, Vicari A et al (2002) Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces. Eur J Immunol 32(1):231–242. doi:10.1002/1521-4141(200201)32:1<231:AID-IMMU231>3.0.CO;2-8 PubMedCrossRef

Viola A, Luster AD (2008) Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol 48:171–197. doi:10.1146/annurev.pharmtox.48.121806.154841 PubMedCrossRef

White GE, Iqbal AJ, Greaves DR (2013) CC Chemokine Receptors and Chronic Inflammation–Therapeutic Opportunities and Pharmacological Challenges. Pharmacol Rev 65(1):47–89. doi:10.1124/pr.111.005074 PubMedCrossRef

Breland UM, Michelsen AE, Skjelland M, Folkersen L, Krohg-Sørensen K, Russell D, Ueland T et al (2010) Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovascular research 86(2):265–273. doi:10.1093/cvr/cvq044 PubMedCrossRef

Yamaguchi A, Nozawa K, Fujishiro M, Kawasaki M, Suzuki F, Takamori K, Ogawa H et al (2012a) CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis. Modern Rheumatol. doi:10.1007/s10165-012-0752-4

Yamaguchi A, Nozawa K, Fujishiro M, Kawasaki M, Takamori K, Ogawa H, Sekigawa I et al (2012b) Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis. Immunopharmacol Immunotoxicol 34(5):852–857. doi:10.3109/08923973.2012.664149 PubMedCrossRef

Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ (2003) Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74(3):448–455PubMedCrossRef

Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF et al (1999) C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationshi. J Immunol (Baltimore, Md.: 1950) 163(7):3976–3984

Zlotnik A, Yoshie O (2012) The chemokine superfamily revisited. Immunity 36(5):705–716. doi:10.1016/j.immuni.2012.05.008 PubMedCrossRef

Titel: The multiple faces of CCL13 in immunity and inflammation
verfasst von: E. Mendez-Enriquez
E. A. García-Zepeda
Publikationsdatum: 01.12.2013
Verlag: Springer Basel
Erschienen in: Inflammopharmacology / Ausgabe 6/2013
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-013-0177-5

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

The multiple faces of CCL13 in immunity and inflammation

Abstract

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2013

Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats

Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management

Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro

Erratum to: Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis

The anti-inflammatory effect of diclofenac is considerably augmented by topical capsaicinoids-containing patch in carrageenan-induced paw oedema of rat

Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture